Market Overview

Pluristem Awarded Placental Cell Therapy Patent in Australia

Pluristem Therapeutics (Nasdaq: PSTI) today announced it has been granted a new patent in Australia. Patent #2008300185, titled "Methods for Cell Expansion and Uses of Cells and Conditioned Media Produced thereby for Therapy," covers the use of adherent placental cells for the treatment of ischemia, which is a restriction of blood supply to tissues, and for treatments of conditions requiring connective tissue repair or regeneration.

See full press release

Posted-In: News Guidance Contracts Management Global

 

Related Articles (PSTI)

Around the Web, We're Loving...

Get Benzinga's Newsletters